Category Archives: Psoriasis

By Dennis Thompson HealthDay Reporter

WEDNESDAY, May 29 (HealthDay News) -- People with psoriasis who lose weight could experience some relief from the symptoms of their chronic skin disease, according to a small new study.

A clinical trial based in Denmark found that obese patients with psoriasis who lost weight through a low-calorie diet experienced a significant improvement in their quality of life, compared to obese psoriasis patients who didn't lose weight.

The patients in the weight-loss group reported less stinging and burning, were less likely to be embarrassed by unsightly lesions, and found that their condition affected their everyday life less often, said Dr. Peter Jensen, of the Copenhagen University Hospital Gentofte, and colleagues.

"Our results emphasize the importance of weight loss as part of a multimodal treatment approach to effectively treat both the skin condition and its [related medical] conditions in overweight patients with psoriasis," the researchers said in the study, which was published online May 29 in the journal JAMA Dermatology.

Psoriasis is a chronic inflammatory skin disease that develops when a person's immune system malfunctions and causes skin cells to grow too quickly. The new skin cells form in days rather than weeks and pile up on the skin's surface, causing scaly, painful lesions.

In the randomized clinical trial, 27 patients were assigned to an intervention group that followed a low-calorie diet and 26 patients were assigned to a control group that continued to eat ordinary healthy foods. Researchers tracked psoriasis symptoms and quality of life using two questionnaires.

The patients on a low-calorie diet ended up losing nearly 34 pounds in 16 weeks, and reported improvements in both their psoriasis symptoms and their overall quality of life.

Dermatologists said the study's results are not surprising, but do reinforce the need for overweight or obese people with psoriasis to try to lose weight.

"Obesity is a huge issue for patients with psoriasis," said Dr. Joel Gelfand, an associate professor of dermatology and medical director of the clinical studies unit at the Hospital of the University of Pennsylvania, in Philadelphia. "If you're obese with psoriasis, psoriasis is less likely to get clear."

Visit link:

Weight Loss Might Ease Psoriasis, Study Hints

Public release date: 4-Jun-2013 [ | E-mail | Share ]

Contact: Noe Baker media@psoriasis.org 503-546-8416 National Psoriasis Foundation

PORTLAND, Ore. (June 4, 2013)Six of the top scientists studying psoriasisthe most common autoimmune disease in the country, affecting 7.5 million Americansand psoriatic arthritis, an inflammatory joint and tendon disease affecting up to 30 percent of people with psoriasis, received National Psoriasis Foundation (NPF) research grants totaling $450,000 for projects that aim to discover new treatments and a cure for these chronic diseases.

"National Psoriasis Foundation is dedicated to increasing the number of scientists, dollars and projects dedicated to psoriatic diseases," said Randy Beranek, National Psoriasis Foundation president and CEO. "We are the only organization funding these types of promising research projects, each of which will move us faster toward finding a cure, which is our highest priority."

Learn about the NPF research grant program: http://www.psoriasis.org/research.

Theoharis Theoharides, M.D., Ph.D., professor of pharmacology at Tufts University School of Medicine in Boston, received a two-year, $200,000 Translational Research Grant to take laboratory findings and translate them into real-world applications to manage health. Dr. Theoharides will explore how stress contributes to psoriasis and how molecules derived from chamomile might interrupt this psoriasis-stress connection.

Additionally, five researchers each received a one-year, $50,000 Discovery Grant for early-stage research to advance basic understanding of psoriasis and psoriatic arthritis.

###

The National Psoriasis Foundation is the world's largest charitable funder of psoriasis and psoriatic arthritis research worldwide. Learn more about the Foundation research priorities at http://www.psoriasis.org/research.

About the National Psoriasis Foundation

Read more:

National Psoriasis Foundation awards $450,000 in research grants

Anaheim, CA (PRWEB) June 04, 2013

TriDerma, a maker of specialized skin care, announced the launch of its new Psoriasis Control Shampoo, a medical strength shampoo that helps provide fast relief for the itchy and scaly scalp that are symptoms of psoriasis, dandruff and dermatitis.

Psoriasis can affect any skin surface and is marked by a build-up of skin cells called scales. Patches of skin affected by psoriasis become itchy, dry, red, and sometimes painful. It is estimated that half of the 7.5 million Americans with psoriasis are affected by scalp psoriasis. It can appear as one or multiple patches on the scalp, affect the entire scalp, and spread beyond the scalp to the forehead, back of the neck, or behind the ears. It can be difficult to treat psoriasis of the scalp because of the difficulty applying topical psoriasis treatments to the affected area.

TriDerma Psoriasis Control Shampoo contains 3% salicylic acid. Salicylic Acid, approved by the FDA as a treatment for psoriasis, gently exfoliates flakes and scales, and helps relieve itching, redness and irritation due to psoriasis and seborrheic dermatitis. Healing botanicals in the companys proprietary AP4 Genuine Virgin Aloe complex are naturally anti-inflammatory and moisturizing to help relieve and prevent flaking and scaling. Specialized itch-fighting ingredients help stop the urge to scratch. Nourishing botanicals, Pro Vitamin B5 and Vitamin E help promote healthy scalp and hair. TriDerma also added a botanical color protectant, so the shampoo is safe for color-treated hair.

TriDerma has over ten years of experience in the psoriasis segment with its Psoriasis Control Skin Healing Cream. Holly Ahearn, Director of Research and Development at TriDerma, says, Psoriasis Control Shampoo was created in response to customer demand for a shampoo that does not smell like medicine, targets psoriasis symptoms, and also makes hair look great. Psoriasis Control Shampoo is an exclusive salon formula. Ms. Ahearn says it is formulated like a luxurious salon treatment, leaving hair soft and manageable, looking beautiful and smelling fresh and clean.

TriDerma Psoriasis Control Shampoo can be ordered online at http://www.triderma.com.

About Triderma

Headquartered in Anaheim, California, TriDerma has provided fast healing without a prescription for 21 years. Founded upon the determination of one woman seeking a natural healing solution, TriDerma now manufactures over 50 products available online and in the First Aid, Skin Care and Baby section of drugstores and supercenters across the U.S. and the world. TriDerma formulas are purpose-driven to help heal specific skin conditions without the use of cortisone, steroids, parabens or other harmful ingredients. Proprietary formulations made in the USA ensure quality and efficacy are never compromised. TriDerma is a women-owned company. For more information and a store locator, go to http://www.Triderma.com. Follow us on Facebook at Facebook.com/TriDerma.

Contact: Angie Echele 636-633-6499

Originally posted here:

New Psoriasis Controlâ„¢ Shampoo Combines Salon Luxury with Fast Relief for Psoriasis, Dandruff and Dermatitis of the ...

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/55snsq/global_plaque) has announced the addition of the "Global Plaque Psoriasis Pipeline Capsule - 2013" report to their offering.

Fore Pharma's latest report Global Plaque Psoriasis Pipeline Capsule - 2013' provides up-to-date information on key Research and Development (R&D) activities in the global plaque psoriasis market. It covers active plaque psoriasis pipeline molecules in clinical trials, preclinical research, and drug discovery.

This report helps executives track competitor pipeline molecules. The pipeline data presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

The scope of the report includes information on plaque psoriasis pipeline molecules by clinical trial stages, company, mechanism of action, and country (The US, Germany, France, Italy, Spain, UK, Japan, and Rest of the World). Plaque psoriasis pipeline molecules licensing activities are also covered in this report.

Key Topics Covered

1. Plaque Psoriasis - Disease Overview

2. Plaque Psoriasis Pipeline Overview

3. Plaque Psoriasis Pipeline by Geography

4. Plaque Psoriasis Phase 3 Clinical Trial Pipeline Insights

Continued here:

Research and Markets: Global Plaque Psoriasis Pipeline Capsule - 2013